David J Whellan
Overview
Explore the profile of David J Whellan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
6388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirzai S, Chen H, Pastva A, Reeves G, Mentz R, Kitzman D, et al.
Circ Heart Fail
. 2025 Feb;
:e012550.
PMID: 39945061
No abstract available.
2.
Sankisa D, Tatum R, Saxena A, Whellan D, Alvarez R, Morris R, et al.
J Gen Intern Med
. 2024 Oct;
PMID: 39358498
Background: U.S. News and World Report 2022-2023 hospital rankings were used to investigate the leadership practices and organizational structure of ranked healthcare institutions. Methods: Institutional variables including physician leadership status,...
3.
Corsi D, Dikdan S, Upadhyay N, Chen H, Kitzman D, Mentz R, et al.
J Am Heart Assoc
. 2024 Sep;
13(19):e034366.
PMID: 39291487
Background: The REHAB-HF (Rehabilitation Therapy in Older Acute Heart Failure Patients) trial demonstrated that a transitional, tailored, progressive rehabilitation intervention improved physical function, 6-minute walk distance, frailty, quality-of-life, and depression...
4.
Physical Activity for Patients With Heart Failure With Reduced Ejection Fraction: Pump up the Volume
Whellan D
Circulation
. 2023 Nov;
149(3):189-191.
PMID: 37955620
No abstract available.
5.
Gilbert O, Mentz R, Bertoni A, Kitzman D, Whellan D, Reeves G, et al.
J Am Heart Assoc
. 2023 Oct;
12(21):e030588.
PMID: 37889196
Background The REHAB-HF (Rehabilitation Therapy in Older Acute Heart Failure Patients) randomized trial demonstrated that a 3-month transitional, tailored, progressive, multidomain physical rehabilitation intervention improves physical function, frailty, depression, and...
6.
Dimond M, Fiuzat M, Mentz R, Lala-Trindade A, Whellan D, Walsh M, et al.
JACC Heart Fail
. 2023 Oct;
12(1):226-228.
PMID: 37804314
No abstract available.
7.
Cuchel M, Lee P, Hudgins L, Duell P, Ahmad Z, Baum S, et al.
J Am Heart Assoc
. 2023 Apr;
12(9):e029175.
PMID: 37119068
Background Homozygous familial hypercholesterolemia (HoFH) is a rare, treatment-resistant disorder characterized by early-onset atherosclerotic and aortic valvular cardiovascular disease if left untreated. Contemporary information on HoFH in the United States...
8.
Harrington J, Nixon A, Daubert M, Yow E, Januzzi J, Fiuzat M, et al.
J Card Fail
. 2023 Jan;
29(6):896-906.
PMID: 36632934
Background: We sought to determine whether circulating modifiers of endothelial function are associated with cardiac structure and clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Methods:...
9.
Pandey A, Kitzman D, Nelson M, Pastva A, Duncan P, Whellan D, et al.
JAMA Cardiol
. 2023 Jan;
8(2):167-176.
PMID: 36598761
Importance: Frailty is common among older patients with acute decompensated heart failure (ADHF) and is associated with worse quality of life (QOL) and a higher risk of clinical events. Frailty...
10.
Sharma A, Lam C, Tay W, Yap J, MacDonald M, Razaghizad A, et al.
JACC Asia
. 2022 Dec;
2(5):648-650.
PMID: 36518722
No abstract available.